X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
tau hyperphosphorylation (380) 380
index medicus (325) 325
alzheimer's disease (296) 296
animals (282) 282
neurosciences (258) 258
alzheimers-disease (231) 231
humans (204) 204
phosphorylation (173) 173
mice (145) 145
tau proteins - metabolism (144) 144
tau-hyperphosphorylation (135) 135
biochemistry & molecular biology (119) 119
male (119) 119
oxidative stress (115) 115
brain (110) 110
disease models, animal (92) 92
rats (90) 90
alzheimer disease - metabolism (88) 88
neurodegeneration (85) 85
alzheimer disease - pathology (74) 74
alzheimer’s disease (70) 70
cell biology (70) 70
mouse model (70) 70
alzheimer disease - drug therapy (68) 68
neurology (68) 68
apoptosis (65) 65
pharmacology & pharmacy (64) 64
in-vivo (63) 63
neurodegenerative diseases (63) 63
proteins (63) 63
amyloid beta-peptides - metabolism (60) 60
neurons - metabolism (59) 59
transgenic mice (57) 57
a-beta (56) 56
analysis (55) 55
mice, transgenic (55) 55
neurons (55) 55
amyloid precursor protein (54) 54
memory (54) 54
neurofibrillary tangles (54) 54
tau protein (54) 54
cognitive impairment (53) 53
amyloid-beta (52) 52
phosphorylation - drug effects (52) 52
protein (52) 52
pathology (51) 51
neuroprotective agents - pharmacology (49) 49
clinical neurology (48) 48
hippocampus (48) 48
alzheimers disease (47) 47
female (47) 47
hippocampus - metabolism (46) 46
brain - metabolism (43) 43
mice, inbred c57bl (43) 43
neuroprotection (43) 43
dementia (42) 42
synaptic plasticity (42) 42
transgenic mouse model (42) 42
long-term potentiation (41) 41
neurons - drug effects (41) 41
alzheimer disease (39) 39
kinases (38) 38
tau (38) 38
alzheimer disease - genetics (37) 37
article (37) 37
glycogen-synthase kinase-3 (37) 37
geriatrics & gerontology (36) 36
in-vitro (35) 35
alzheimer disease - physiopathology (34) 34
brain - pathology (34) 34
disease (34) 34
hippocampus - drug effects (34) 34
paired helical filaments (34) 34
rats, sprague-dawley (34) 34
research (34) 34
amyloid beta-protein (33) 33
rodents (33) 33
glycogen (32) 32
biomedicine (31) 31
cell line, tumor (31) 31
activation (30) 30
glycogen synthase kinase 3 - metabolism (30) 30
inhibition (30) 30
neurotoxicity (30) 30
protein phosphatase 2a (30) 30
aging (29) 29
biophysics (29) 29
cognitive ability (29) 29
glycogen-synthase kinase-3-beta (29) 29
signal transduction (29) 29
nervous system (28) 28
peptides (28) 28
cells, cultured (27) 27
mild cognitive impairment (27) 27
neuroprotective agents - therapeutic use (27) 27
signal transduction - drug effects (27) 27
cyclin-dependent kinase-5 (26) 26
expression (26) 26
health aspects (26) 26
spatial memory (26) 26
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2007, Volume 104, Issue 9, pp. 3591 - 3596
Journal Article
Cellular and Molecular Neurobiology, ISSN 0272-4340, 5/2016, Volume 36, Issue 4, pp. 483 - 495
Receptor for advanced glycation end products (RAGE) is a receptor of the immunoglobulin super family that plays various important roles under physiological and... 
Neurosciences | Biomedicine | Receptor for advanced glycation end products | Tau hyperphosphorylation | Alzheimer’s disease | Neurobiology | Beta-amyloid | Cell Biology | Cognitive impairment
Journal Article
Pharmacological Research, ISSN 1043-6618, 01/2019, Volume 139, pp. 512 - 523
Alzheimer’s disease (AD) is a common neurodegenerative disease which is characterized by aggregation of amyloid beta (Aβ) and hyperphosphorylated tau. We... 
Amyloid beta | Tau hyperphosphorylation | Pseudoginsenoside-F11 | Cognitive impairment | Protein phosphatase 2A
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 05/2018, Volume 26, Issue 9, pp. 2551 - 2560
Following the premises of the multitarget-directed ligands approach for the drug R&D against neurodegenerative diseases, where Alzheimer’s disease (AD)... 
Neuroprotection | Multitarget strategy | Tau hyperphosphorylation | Alzheimer’s disease | Gramine analogues | Ca2+ overload | Phosphoprotein phosphatase 2A
Journal Article
Life Sciences, ISSN 0024-3205, 09/2018, Volume 208, pp. 96 - 101
Amyloid β (Aβ) peptide can cause neurotoxicity in Alzheimer's disease (AD). The main purpose of the present study is to investigate the protective role of... 
NF-κB | Alzheimer's disease (AD) | Asiatic acid | PI3K/Akt/GSK-3β signaling | Tau hyperphosphorylation | Aβ25–35 | Index Medicus
Journal Article
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 05/2012, Volume 64, Issue 7, pp. 614 - 628
Journal Article